Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1.

Antimicrobial agents and chemotherapy - 1 Feb 2004

Parkin N T, Hellmann N S, Whitcomb J M, Kiss L, Chappey C, Petropoulos C J

Abstract excerpt

Wild-type viruses from the ViroLogic phenotype-genotype database were evaluated to determine the upper confidence limit of the drug susceptibility distributions, or "biological cutoffs," for the PhenoSense HIV phenotypic drug susceptibility assay. Definition of the natural variation in drug susce...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Databases, Factual
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Microbial Sensitivity Tests

Share to Mutation

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 14742192
DOI: 10.1128/AAC.48.2.437-443.2004
PMCID: PMC321508

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14742192-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1.PMID 14742192Read ↗

Comparison of the precision and sensitivity of the Antivirogram and PhenoSense HIV drug susceptibility assays.Semantic proximity Read ↗

World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing.Semantic proximity Read ↗

Comparative analysis of two commercial phenotypic assays for drug susceptibility testing of human immunodeficiency virus type 1.Semantic proximity Read ↗

Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infection.Semantic proximity Read ↗

Short communication prevalence of susceptibility to etravirine by genotype and phenotype in samples received for routine HIV type 1 resistance testing in the United States.Semantic proximity Read ↗

Phenotypic susceptibilities to tenofovir in a large panel of clinically derived human immunodeficiency virus type 1 isolates.Semantic proximity Read ↗

A direct comparison of drug susceptibility to HIV type 1 from antiretroviral experienced subjects as assessed by the antivirogram and PhenoSense assays and by seven resistance algorithms.Semantic proximity Read ↗

A comparison of the phenotypic susceptibility profiles of emtricitabine and lamivudine.Semantic proximity Read ↗

A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype.Semantic proximity Read ↗

Antivirogram or phenosense: a comparison of their reproducibility and an analysis of their correlation.Semantic proximity Read ↗

Role of HIV phenotypic assays in the management of HIV infection.Semantic proximity Read ↗

Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.